文献速递慢性肾脏病

全球慢性肾脏病检测与监测的组织架构:多国横断面调查

Organization and Structures for Detection and Monitoring of CKD Across World Countries and Regions: Observational Data From a Global Survey.
PubMed 文献 · Am J Kidney Dis · 2024-05-22

该研究基于国际肾脏病学会2022年6月至9月对167个国家利益相关者的多国横断面调查,描述慢性肾脏病检测与监测的组织架构现状。结果显示仅19%报告有慢性肾脏病登记系统,25%将检测项目纳入国家政策;高危人群病例发现较普遍,但低收入和 lower-middle-income 国家获取eGFR和UACR工具受限。

要点

  • 全球仅19%国家报告慢性肾脏病登记系统,25%将检测项目纳入国家政策。
  • 糖尿病(91%)和高血压(89%)患者的常规病例发现较为普遍。
  • 低收入和 lower-middle-income 国家在初级和二级/三级医疗层面获取eGFR和UACR均受限。

核心结论

  • 全球慢性肾脏病早期识别的组织架构(监测系统、检测项目与工具)存在显著异质性,需缩小差距以预防慢性肾脏病及其并发症。

研究设计与样本

  • 多国横断面调查,纳入参与国际肾脏病学会调查的167个国家的利益相关者(肾脏病领导者、政策制定者和患者倡导者),调查时间为2022年6月至9月。
  • 采用描述性统计分析。

主要发现

  • 19%(n=31)的参与国家报告有慢性肾脏病登记系统,25%(n=40)报告将慢性肾脏病检测项目作为国家政策的一部分实施。
  • 实施检测项目的国家中,50%(n=20)采用反应性方法(发现病例后管理),50%(n=20)在高危人群中主动进行病例发现。
  • 高危人群常规病例发现较为普遍,尤其是糖尿病(n=152;91%)和高血压(n=148;89%)。
  • 低收入国家初级医疗层面eGFR可及性为22%、UACR为28%,lower-middle-income国家分别为39%和39%。
  • 低收入国家二级/三级医疗层面eGFR可及性为39%、UACR为44%,lower-middle-income国家分别为73%和70%。

临床怎么用

  • 应优先在高危人群(如糖尿病和高血压患者)中推进慢性肾脏病常规病例发现。
  • 需关注低收入和 lower-middle-income 国家在初级和二级/三级医疗层面eGFR和UACR检测工具的可及性差距。

局限性

  • 缺乏详细数据,无法进行深入分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Established therapeutic interventions effectively mitigate the risk and progression of chronic kidney disease (CKD). Countries and regions have a compelling need for organizational structures that enable early identification of people with CKD who can benefit from these proven interventions. We report the current global status of CKD detection programs. STUDY DESIGN: A multinational cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders, including nephrologist leaders, policymakers, and patient advocates from 167 countries, participating in the International Society of Nephrology (ISN) survey from June to September 2022. OUTCOME: Structures for the detection and monitoring of CKD, including CKD surveillance systems in the form of registries, community-based detection programs, case-finding practices, and availability of measurement tools for risk identification. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Of all participating countries, 19% (n=31) reported CKD registries, and 25% (n=40) reported implementing CKD detection programs as part of their national policies. There were variations in CKD detection program, with 50% (n=20) using a reactive approach (managing cases as identified) and 50% (n=20) actively pursuing case-finding in at-risk populations. Routine case-finding for CKD in high-risk populations was widespread, particularly for diabetes (n=152; 91%) and hypertension (n=148; 89%). Access to diagnostic tools, estimated glomerular filtration rate (eGFR), and urine albumin-creatinine ratio (UACR) was limited, especially in low-income (LICs) and lower-middle-income (LMICs) countries, at primary (eGFR: LICs 22%, LMICs 39%, UACR: LICs 28%, LMICs 39%) and secondary/tertiary health care levels (eGFR: LICs 39%, LMICs 73%, UACR: LICs 44%, LMICs 70%), potentially hindering CKD detection. LIMITATIONS: A lack of detailed data prevented an in-depth analysis. CONCLUSIONS: This comprehensive survey highlights a global heterogeneity in the organization and structures (surveillance systems and detection programs and tools) for early identification of CKD. Ongoing efforts should be geared toward bridging such disparities to optimally prevent the onset and progression of CKD and its complications. PLAIN-LANGUAGE SUMMARY: Early detection and management of chronic kidney disease (CKD) is crucial to prevent progression to kidney failure. A multinational survey across 167 countries revealed disparities in CKD detection programs. Only 19% reported CKD registries, and 25% implemented detection programs as part of their national policy. Half used a reactive approach while others actively pursued case-finding in at-risk populations. Routine case-finding was common for individuals with diabetes and hypertension. However, limited access to gold standard tools such as estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR), especially in low-income and lower-middle income countries, may hinder CKD detection. A global effort to bridge these disparities is needed to optimally prevent the onset and progression of CKD and its complications.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Tungsanga S, Fung W, Okpechi IG, et al. Organization and Structures for Detection and Monitoring of CKD Across World Countries and Regions: Observational Data From a Global Survey. Am J Kidney Dis. 2024. PMID: 38788792. doi:10.1053/j.ajkd.2024.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。